Docetaxel plus S‑1 versus cisplatin plus S‑1 in unresectable gastric cancer without measurable lesions: a randomized phase II trial (HERBIS‑3)

Yukinori Kurokawa,Jin Matsuyama,Kazuhiro Nishikawa,Atsushi Takeno,Yutaka Kimura,Kazumasa Fujitani,Ryohei Kawabata,Yoichi Makari,Tetsuji Terazawa,Hisato Kawakami,Daisuke Sakai,Toshio Shimokawa,Taroh Satoh

Gastric Cancer24,428-434(2021)